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J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5 B37METHODS Blinded angiographic core laboratory analysis was
completed in 10,939 of 10,942 randomized patients in PHOENIX. 48-
hour outcomes were analyzed according to the number of angio-
graphic high-risk lesion characteristics present (bifurcation, left main,
thrombus, angulated, tortuous, eccentric, calciﬁed, long (>20 mm), or
multi-lesion PCI), in all patients and separately in those with acute
coronary syndromes (ACS; non-ST-segment elevation MI and STEMI)
and stable ischemic heart disease (SIHD).
RESULTS Among all 10,939 patients, cangrelor reduced the 48-hour
rate of MACE by 21% (4.7% vs. 5.9%, OR [95%CI] ¼ 0.79 [0.67, 0.93],
P¼0.006) as compared to clopidogrel. 1,904 (17.4%) patients had
0 lesions with any high-risk PCI lesion characteristics, while 3,440
(31.4%), 3,064 (28.0%), and 2,531 (23.1%) patients had lesions with 1, 2
and 3 high-risk PCI characteristics, respectively. The 48 hour MACE
rate increased progressively with lesion complexity (from 2.5% to
4.1% to 6.6% to 7.5% in patients with lesions with 0, 1, 2 and 3 high-
risk PCI characteristics (P<0.0001). The reduction in 48-hour
MACE with cangrelor compared to clopidogrel was present and
consistent regardless of PCI lesion complexity, in all patients and in
those with ACS and SIHD (Figure). In a logistic regression model, the
number of high-risk PCI characteristics (adjOR [95%CI] ¼ 1.31 [1.23,
1.39], P<0.0001), SIHD vs. ACS (adjOR [95%CI] ¼ 1.69 [1.41, 2.02],
P<0.0001) and cangrelor vs. clopidogrel randomization (adjOR [95%
CI] ¼ 0.78 [0.66, 0.92], P¼0.004) were independent predictors of 48-
hour MACE.
CONCLUSIONS Compared to a loading dose of clopidogrel, the
potent, rapidly acting, intravenous ADP antagonist cangrelor reduces
48-hour MACE regardless of baseline lesion complexity and clinical
presentation.
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BACKGROUND Serial follow-up optical coherence tomography (OCT)
was used to evaluate the effect of optimal lipid-lowering on qualita-
tive changes in neointimal tissue characteristics after drug-eluting
stent (DES) implantation.METHODS 218 DES-treated patients who received statin therapy were
examined with serial follow-up OCT. First and second follow-up OCT
evaluations were performed approximately 6 and 18 months after the
index procedure. According to the level of low-density lipoprotein
cholesterol (LDL-C) measured at the second follow-up, patients were
divided into two groups. The optimal lipid-lowering group (n¼121)
had an LDL-C reduction of 50%, or an LDL-C level 70mg/dL, and
the conventional group (n¼97). Neointimal characteristics were
qualitatively categorized as homogeneous vs. non-homogeneous
(heterogeneous or layered) patterns using OCT. The qualitative
changes of neointimal tissue characteristics between the ﬁrst and
second follow-up OCT examinations were assessed.
RESULTS Between the ﬁrst and second follow-up OCT procedures,
the neointimal cross-sectional area increased more substantially in the
conventional group (0.4mm2 vs. 0.2mm2 in the optimal lipid-lowering
group, p¼0.01). The neointimal pattern changed from homogeneous to
non-homogeneous less often in the optimal lipid-lowering group (1.3%,
1/77, p<0.001) than in the conventional group (15.3%, 11/72, p¼0.44).
Optimal LDL-C reduction was an independent predictor for the pre-
vention of neointimal tissue pattern change from homogeneous to
non-homogeneous (odds ratio: 0.04, 95% conﬁdence interval:
0.01w0.41, p¼0.006).Table 4. Independent predictors of neointimal change from homogeneous to non-homogeneous patterns
observed by serial follow-up optical coherence tomographyVariableUnivariate Analysis Multivariate AnalysisOR (95% CI) p OR (95% CI) pBaseline LDL-C>100mg/dL 0.89 (0.25w3.19) 0.85Optimal LDL-C control 0.07 (0.01w0.58) 0.01 0.04 (0.01w0.41) 0.006Male 0.38 (0.12w1.26) 0.12 0.67 (0.14w3.11) 0.61Age 1.07 (0.99w1.15) 0.08 1.13 (1.01w1.27) 0.03Diabetes mellitus 0.87 (0.22w3.38) 0.84 1.43 (0.27w7.48) 0.68Hypertension 0.78 (0.24w2.59) 0.68 0.24 (0.05w1.29) 0.101st-generation drug-eluting
stents2.44 (0.73w8.08) 0.15 1.67 (0.39w7.13) 0.49Initial presentation as acute
coronary syndrome0.99 (0.30w3.30) 0.99 0.55 (0.11w2.80) 0.47CONCLUSIONS In conclusion, this serial OCT study suggests that an
intensive reduction of LDL-C could prevent the non-homogeneous
change of the neointima and the increase in neointimal cross-
sectional area compared with the conventional LDL-C control.
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